American Vanguard Corp (AVD)

NYSE · Basic Materials · Agricultural Inputs · USA

American Vanguard Corp is a micro cap company (market value under $300 million) in the Agricultural Inputs industry.

American Vanguard Corporation manufactures and distributes chemical, biological, and biorational products for agricultural, commercial, and consumer uses. Operating through subsidiaries including AMVAC Chemical Corporation in the United States and international operations spanning Latin America, the Asia-Pacific region, and India, the company produces insecticides, fungicides, herbicides, and soil health solutions for growers and retailers.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the American Vanguard Corp stock.

Our verdict on AVD

No reliable verdict: intrinsic value $5.88 per share, market price $0.74 (as of 2026-11-17).

Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $5.88: 8 times the price of $0.74. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

ETFs with the most weight in AVD

13 more funds hold it; the full list is part of the paid plan.

Browse

Peers in Agricultural Inputs

All 14 Agricultural Inputs stocks

Is AVD undervalued or overvalued?

We do not publish a verdict on AVD. Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $5.88: 8 times the price of $0.74. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.

What is the intrinsic value of AVD?

We do not publish one (as of the 2026-11-17 close). Its earnings through the cycle, capitalised at its cost of capital, would put the shares at $5.88: 8 times the price of $0.74. A gap that size says more about a model than about the market. It usually means heavy debt, where a small error in the value of the business becomes a large one in the value of the shares, or a business our method does not describe. We do not publish a verdict on this one.